Category: Peptides

Filter By
Brand: Biosensis Brand: Cayman Chemical Brand: Genetex Brand: Histosure Brand: Signalchem Clear all
Thr-phosphopeptide Thr-phosphopeptide

Thr-phosphopeptide

Reference: T69-58
€0.00 (tax incl.)
The Thr-phosphopeptide sequence (KRT(p)IRR) is derived from human NR2F6 (amino acids 79-84) and is suitable as a substrate for PP2A, PP2B, PP2C and PP1.
Thr-phosphopeptide-3 Thr-phosphopeptide-3

Thr-phosphopeptide-3

Reference: T72-58-01
€0.00 (tax incl.)
The Thr-phosphopeptide-3 sequence (RRAT(p)VA) is a phosphorylated threonyl derivative from human pyruvate kinase (amino acids 40-45) and is suitable as a substrate for PP1, PP2A, and PP2C (e.g. WIP1).
Tyr-phosphopeptide-2 Tyr-phosphopeptide-2

Tyr-phosphopeptide-2

Reference: T70-58
€0.00 (tax incl.)
The Tyr-phosphopeptide-2 sub peptide sequence (DADEY(p)LIPDQG) is based on mouse epidermal growth factor receptor isoform 1 (amino acid 1014-1024).
ULKtide ULKtide

ULKtide

Reference: U01-58-1
€0.00 (tax incl.)
The ULKtide synthetic peptide [YANWLAASIYLDGKKK] is routinely evaluated as a substrate for ULK family kinase assays.
ZIPtide ZIPtide

ZIPtide

Reference: Z16-58
€0.00 (tax incl.)
The ZIPtide substrate peptide sequence (KKLNRTLSFAEPG) is routinely evaluated as a substrate for DAPK3 (ZIPK).
Amyloid beta, 1-42, HFIP-treated Purified Peptide-50 μg Amyloid beta, 1-42, HFIP-treated Purified Peptide-50 μg

Amyloid beta, 1-42, HFIP-treated Purified Peptide-50 μg

Reference: PE-1749-50
€0.00 (tax incl.)
Synthetic beta-amyloid Aβ1-42 was monomerized by HFIP (hexafluoro-2-propanol) treatment and dried. One vial contains 50 μg monomeric Aβ peptide that can be used to form solutions of unaggregated Aβ monomers,...
Amyloid beta, 1-42, oligomeric, Stabilized Peptide-2 x 500 ng Amyloid beta, 1-42, oligomeric, Stabilized Peptide-2 x 500 ng

Amyloid beta, 1-42, oligomeric, Stabilized Peptide-2 x 500 ng

Reference: PE-1750-1000
€0.00 (tax incl.)
A proprietary preparation of human amyloid beta peptide (amino acids 1-42) that was initially monomerized by HFIP-treatment and then allowed to form oligomers by the procedure described in Youmans KL et al., 2012,...

Menu

Settings

Please sign in first.

Sign in